
Professor of Economics @WashUOlin & School of Public Health
Joined February 2009
- Tweets2.8K
- Following1.1K
- Followers1.9K
- Likes2.2K
Replying to @roozbeh52
Still mostly empty. I guess if Delta is also involved then it's less surprising they screwed up their attempts at clever pricing tactics. – at Atlanta, GA
Struggling to understand this pricing strategy @florianederer. Got our Tier 1 seats through FIFA lottery and would have gladly paid more for "Tier 0" or whatever these better seats are considered (the only empty ones in the whole stadium) but still have no idea how we could have purchased them through FIFA. – at Atlanta, GA
I just went 82-0, think you can go 82-0? 82-0.com/share?id=H5DsvRWLk0… #NBA #82and0 – at Raleigh, NC
Replying to @florianederer
The market clearly has a view of the long-term health effects – at Clayton, MO
Best marketing imaginable for @Clear — shorter wait than Starbucks right now when even TSA Pre line going all the way out the terminal – at Morrisville, NC
Excited to take part in @TheAtlantic and @WashUOlin’s Business of Health summit on October 15.
I'll be leading a discussion with Jesse Hunter and Aaron Chrisman on how ownership and investment models in health care can better align with long-term value and outcomes.
Join virtually from anywhere: bit.ly/3KZ8ZBB
We use Medicare’s annual changes to facility quality scores to identify the causal effect of strategic patient dropping
Dialysis chains use a number of other strategies to maximize profits at the expense of patients, such as forcing out those who might harm their performance scores
nber.org/system/files/workin…
In the paper, we could use the body’s natural response at elevation (the body produces more red blood cells at higher elevations and as a result patients need less EPO to manage their anemia) to identify the causal effect of excessive doses on patients’ outcomes. The pursuit of profits was killing dialysis patients.











